Aravis Venture Associates

Aravis is a Swiss venture capital and private equity firm founded in 2001 and headquartered in Zurich. The firm specializes in early-stage and growth-oriented investments within the life sciences and renewable energy sectors. Aravis has a strong track record in the biotechnology industry, having co-founded or seeded several successful Swiss companies such as NovImmune, Glycart, and Evolva. The firm manages multiple funds, including Aravis Biotech I and II, and provides hands-on strategic support to its portfolio companies to accelerate their development from inception to exit. With over USD 400 million deployed, Aravis focuses on high-tech growth investments that balance financial, commercial, and human aspects.